1 Khamdang S, Takeda M, Noshiro R, et al. Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs[J].Pharmacol Exp Ther, 2002;303:534-539. 2 Mizuno N, Sugiyama Y.Drug transporters:Their role and importance in the selection and development of drugs[J].Drug Metabol Pharmacokin, 2002;17:93-108. 3 Keppler D, Leier I, Jedlitschky G, et al. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance protein MRP1 and its apical isoform MRP2[J].Chem Biol Interact, 1998;24:153-161. 4 Keppler D, Kö nig J, Büchler M.The canalicular multidrug resistance protein, cMRP MRP2, a novel conjugate export pump expressed in the apical membrane of hepatocytes[J].Advan Enzyme Regul, 1997;37:321-333. 5 Morikawa A, Goto Y, Suzuki H, et al. Biliary excretion of 17-beta-estradiol 17beta-D-glucuronide is predominantly mediated by cMOAT/MRP2[J].Pharm Res, 2000;17:546-52. 6 Kenny JR, Maggs JL, Meng X, et al. Syntheses and characterization of the acyl glucuronide and hydroxy metabolites of diclofenac[J].Med Chem, 47:2816-2825. 7 Mano N, Goto T, Nikaido A, et al. Inhibition of the rat hepatic microsomal flurbiprofen acyl glucuronidation by bile acids[J].J Pharm Sci, 2003;92:2098-108. 8 Ito K, Suzuki H, Hirohashi T, et al.. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR[J].Am J Physiol, 1997;272:G16-22. 9 Chen C, Scott D, Hanson E, et al. Impact of Mrp2 on the biliary excretion and intestinal absorption of furosemide, probenecid, and methotrexate using Eisai hyperbilirubinemic rats[J]. Pharm Res, 2003;20:31-37. 10 Nagao T, Tanino T, Iwaki M.Stereoselective pharmacokinetics of flurbiprofen and formation covalent adducts with plasma protein in adjuvant-induced arthritic rats[J].Chirality, 2003;15: 423-428. 11 Soars MG, Mattiuz EL, Jackson DA, et al. Biosynthesis of drug glucuronides for use as authentic standards[J].J Pharmacol ToxicolMetho, 2002;47:161-168. 12 Meunier CJ, Verbeeck RK.Glucuronidation of R-and S-ketoprofen, acetaminophen, and diflunisal by liver microsomes of adjuvant-induced arthritic rats[J].Drug Metab Dispos, 1999; 27:26-31 13 Menzel S, Beck WS, Brune K, et al. Stereoselectivity of biliary excretion of 2-arylpropionates in rats[J].Chirality, 1993; 5:422-427. 14 Beck WS, Geisslinger G, Engler H, et al. Pharmacokinetics of ibuprofen enantiomers in dogs[J].Chirality, 1991;3:165-169. 15 Castillo M, Smith PC.Disposition and reactivity of ibuprofen and ibufenac acyl glucuronides in vivo in the rhesus monkey and in vitro with human serum albumin[J].Drug Metab Dispos, 1995;23:566-72. 16 TaghianM, Tran TA, Bresson-Hadni S, et al. Acute vanishing bile duct syndrome after ibuprofen therapy in a child[J].J Pediatr, 2004;145:273-276. 17 Alam I, Ferrell LD, Bass NM.Vanishing bile duct syndrome temporally associated with ibuprofen use[J].Am J Gastroenterol, 1996;91:1626-1630. 18 Ackerman Z, Cominelli F, Reynolds TB.Effect of misoprostol on ibuprofen-induced renal dysfunction in patients with decompensated cirrhosis:results of a double-blind placebo-controlled parallel group study[J].Am J Gastroenterol, 2002;97:2033-2039. 19 Ortiz DF, Li S, Iyer R, et al. MRP3, a new ATP-binding cassette protein localized to the canalicular domain of the hepatocyte[J].Am J Physiol Gastrointest Liver Physiol, 1999;276: G1493-G1500. 20 Akita H, Suzuki H, Sugiyama Y.Sinusoidal efflux of taurocholate correlates with the hepatic expression level of Mrp3[J]. Biochem Biophys Res Commun, 2002;299:681-687. 21 Ogawa1 K, Suzuki H, Hirohashi T, et al. Characterization of inducible nature of MRP3 in rat liver[J].Am J Physiol Gastrointest Liver Physiol, 2000;278:G438-G446. 22 Kato Y, Igarashi T, Sugiyama Y, et al. Both cMOAT MRP2 and another unknown transporter(s)are responsible for the biliary excretion of glucuronide conjugate of the nonpeptide angiotensin II antagonist[J].Telmisaltan, 2000;28:1146-1148. |